SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-20-016390
Filing Date
2020-08-20
Accepted
2020-08-20 10:44:09
Documents
1
Period of Report
2020-08-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2813
  Complete submission text file 0001493152-20-016390.txt   4233
Mailing Address 5439 LOCKHURST DRIVE WOODLAND HILLS CA 91367
Business Address
WEINGARTEN ROBERT N (Reporting) CIK: 0001135337 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51476 | Film No.: 201119168

Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Issuer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations